Tracking the fight for life after a stem cell transplant
NCT ID NCT07328724
Summary
This study aims to learn what happens when patients become critically ill after a stem cell transplant. It will follow 4000 patients in China who are admitted to intensive care after their transplant. Researchers will collect detailed information on their health, treatments, and survival to better understand these serious complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Harbin Medical University
Harbin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
First Affiliated Hospital of Zhejiang University
Hangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xinqiao hospital of the third military medical university
Chongqing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.